An in silico model to demonstrate the effects of Maspin on cancer cell dynamics

Journal of Theoretical Biology

Volumn 388, Issue , 2016, Pages 37-49

  Al Mamun, M A ^a   Farid, D M ^b   Ravenhil, L ^c   Hossain, M A ^d   Fall, C ^c   Bass, R ^c  

^a Cornell University ^*  (United States)

^b UNITED INTERNATIONAL UNIVERSITY   (Bangladesh)

^c NORTHUMBRIA UNIVERSITY   (United Kingdom)

^d ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

Author keywords

Cellular automata; Clustering; Serine protease inhibitor; SERPINB5; Tumor growth

Indexed keywords

MASPIN; PROTEIN BINDING; SERINE PROTEINASE INHIBITOR; SERPIN-B5;

CANCER; CELL ORGANELLE; EXPERIMENTAL STUDY; INHIBITOR; PROTEIN; TUMOR;

ALGORITHM; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COMPUTER MODEL; CONTROLLED STUDY; DYNAMICS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NERVE CELL NETWORK; POSITIVE FEEDBACK; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; CELL ADHESION; CELL MOTION; COMPUTER SIMULATION; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ALGORITHMS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTER SIMULATION; EXTRACELLULAR MATRIX; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; SERPINS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84946203511     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2015.10.007     Document Type: Article

References (57)

1. Al-Mamun, M.A., Kazmi, N., Hossain, M.A., Vickers, P., Jiang, Y., 2012. An intelligent decision support system for personalized cancer treatment. In: CIS2012: Proceedings of the 11th IEEE Conference on Cybernetic Intelligent Systems, 23-24 August 2012. Limerick, Ireland. doi: http://dx.doi.org/10.1109/CIS.2013.6782159.
2. Al-Mamun M.A., Hossain M.A., Alam M.S., Bass R. A cellular automaton model of the effects of maspin on cell migration. Adv. Intell. Syst. Comput. 2013, 222:53-60. 10.1007/978-3-319-00578-2_8.
3. Al-Mamun M.A., Brown L., Hossain M.A., Fall C., Wagstaff L., Bass R. A hybrid computational model for the effects of maspin on cancer cell dynamics. J. Theor. Biol. 2013, 337:150-160. 10.1016/j.jtbi.2013.08.016.
4. Amir S., Margaryan N.V., Odero-Marah V., Khalkhali-Ellis Z., Hendrix M.J. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol. Ther. 2005, 4(4):400-406. 10.4161/cbt.4.4.1617.
5. Andreasen P.A., Egelund R., Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol. Life Sci. 2000, 57(1):25-40. 10.1007/s000180050497.
6. Andasari V., Gerisch A., Lolas G., South A., Chaplain M.A.J. Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation. J. Math. Biol. 2011, 63(1):141-171. 10.1007/s00285-010-0369-1.
7. Anderson A.R.A. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math. Med. Biol. 2005, 22(2):163-186. 10.1093/imammb/dqi005.
8. Anderson A.R.A., Tomlin C.J., Couch J., Gallahan D. Mathematics of the integrative cancer biology program. Interface Focus 2013, 3(4).
9. Bailey C.M., Ellis Z.K., Kondo S., Margaryan N.V., Seftor R.E.B., Wheaton W.W., Amir S., Pins M.R., Schutte B.C., Hendrix M.J.C. Mammary serine protease inhibitor (maspin) binds directly to interferon regulatory factor 6: identification of a novel SERPIN partnership. J. Biol. Chem. 2005, 280(40):34210-34217. 10.1074/jbc.M503523200.
10. Bass R., Fernandez A.M., Ellis V. Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. 2002, 277:46845-46848. 10.1074/jbc.C200532200.
11. Bass R., Wagstaff L., Ravenhill L., Ellis V. Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration. J. Biol. Chem. 2009, 284:27712-27720. 10.1074/jbc.M109.038919.
12. Berardi R., Morgese F., Onofri A., et al. Role of maspin in cancer. Clin. Transl. Med. 2013, 2(1):8. 10.1186/2001-1326-2-8.
13. Bodenstine T.M., Seftor R.E., Khalkhali-Ellis Z., Seftor E.A., Pemberton P.A., Hendrix M.J. Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 2012, 31(3-4):529-551. 10.1007/s10555-012-9361-0.
14. Bodenstine T.M., Seftor R.E., Seftor E.A., et al. Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics. Mol. Cancer Res. 2014, 12(10):1480-1491. 10.1158/1541-7786.MCR-14-0067.
15. Biliran H., Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 2001, 61:8676-8682.
16. Bray Intracellular signaling as a parallel distributed process. J. Theor. Biol. 1990, 143:215-231.
17. Casciari J.J., Sotirchos S.V., Sutherland R.M. Glucose diffusivity in multicellular tumour spheroids. Cancer Res. 1988, 48:3905-3909.
18. Cella N., Contreras A., Latha K., Rosen J.M., Zhang M. Maspin is physically associated with β1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J. 2006, 20:1510-1512. 10.1096/fj.05-5500fje.
19. Chan, H.F., Zhang, Y., Ho, Y.P., Chiu, Y.L., Jung, Y. and Leong, K.W., 2013. Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Scientific Reports, 3: 3462. http://dx.doi.org/10.1038/srep03462.
20. Chen M., Miao D. Interval set clustering. Expert Syst. Appl. 2011, 38:2923-2932. 10.1016/j.eswa.2010.06.052.
21. Conde I.R., Chaplain M.A.J., Anderson A.R.A. Mathematical modeling of cancer cell invasion of tissue. Math. Comput. Model. 2008, 47:533-545. 10.1016/j.mcm.2007.02.034.
22. Deisboeck T.S., Wang Z., Macklin P., Cristini V. Multiscale cancer modeling. Annu. Rev. Biomed. Eng. 2011, 13(1):127-155. 10.1146/annurev-bioeng-071910-124729.
23. Domschke P., Trucu D., Gerisch A., Chaplain M A.J. Mathematical modelling of cancer invasion: Implications of cell adhesion variability for tumour infiltrative growth patterns. J. Theor. Biol. 2014, 361:41-60. 10.1016/j.jtbi.2014.07.010.
24. Edelman L.B., Eddy J.A., Price N.D. In silico models of cancer. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2(4):438-459. 10.1002/wsbm.75.
25. Endsley M.P., Yanqiu Hu, Yong Deng, et al. Maspin, the molecular bridge between the plasminogen activator system and β1 integrin that facilitates cell adhesion. J. Biol. Chem. 2011, 286(28):24599-24607. 10.1074/jbc.M111.235788.
26. Freyer J.P., Sutherland R.M. Regulation of growth saturation and development of necrosis in emt6/ro multicellular spheroids by the glucose and oxygen supply. Cancer Res. 1986, 46:3513-3520.
27. Gerlee P., Anderson A.R.A. An evolutionary hybrid cellular automaton model of solid tumour growth. J. Theor. Biol. 2007, 246(4):583-603. 10.1016/j.jtbi.2007.01.027.
28. Gerlee P., Anderson A.R.A. A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J. Theor. Biol. 2008, 250(4):705-722. 10.1016/j.jtbi.2007.10.038.
29. Gerlee P., Anderson A.R.A. Evolution of cell motility in an individual-based model of tumour growth. J. Theor. Biol. 2009, 259(1):67-83. 10.1016/j.jtbi.2009.03.005.
30. Grote J., Susskind S., Vaupel P. Oxygen diffusivity in tumour tissue (DS- carcinosarcoma) under temperature conditions within the range of 20-40 °C. Pflugers Archit. 1977, 372:37-42.
31. Hall M., Frank E., Holmes G., Pfahringer B., Reutemann P., Witten I.H. The weka data mining software: an update. SIGKDD Explor. 2009, 11(1). (accessed 20.11.14). http://www.cs.waikato.ac.nz/ml/weka/.
32. Hanahan D., Weinberg R.A. The hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013.
33. Härmä V., Virtanen J., Mäkelä R., Happonen A., Mpindi J.-P., Knuuttila M., et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 2010, 5(5):e10431. 10.1371/journal.pone.0010431.
34. Johnson D., McKeever S., Stamatakos G., Dionysiou D., Graf N., Sakkalis V., Marias K., Wang Z., Deisboeck T.S. Dealing with diversity in computational cancer modeling. Cancer Inform. 2013, 12(5):115-124. 10.4137/CIN.S11583.
35. Kam Y., Rejniak K.A., Anderson A.R.A. Cellular modeling of cancer invasion: Integration of in silico and in vitro approaches. J. Cell. Physiol. 2012, 227(2):431-438. 10.1002/jcp.22766.
36. Kazmi N., Hossain M.A., Phillips R.M., Al-Mamun M.A., Bass R. Avascular tumour growth dynamics and the constraints of protein binding for drug transportation. J. Theor. Biol. 2012, 313:142-152. 10.1016/j.jtbi.2012.07.026.
37. Kazmi N., Hossain M.A., Phillips R.M. A hybrid cellular automaton model of solid tumor growth and bioreductive drug transport. IEEE/ACM Trans. Comput. Biol. Bioinform. 2012, 9(6):1595-1606. 10.1109/TCBB.2012.118.
38. Klieser W.M., Freyer J.P., Sutherland R.M. Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br. J. Cancer 1986, 53(3):345-353.
39. Lee J.S., Olafsson S. Data clustering by minimising disconnectivity. Inf. Sci. 2011, 181:732-746. 10.1016/j.ins.2010.10.028.
40. Li Z., Shi H.Y., Zhang H.Y. Targeted expression of maspin in tumour vasculatures induces endothelial cell apoptosis. Oncogene 2005, 24:2008-2019. 10.1038/sj.onc.
41. Macklin P., Lowengrub J. Nonlinear simulation of the effect of microenvironment on tumor growth. J. Theor. Biol. 2007, 245(4):677-704. 10.1016/j.jtbi.2006.12.004.
42. Ngamkitidechakul C., Burke J.M., OBrien W.J., Twining S.S. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Investig. Ophthalmol. Vis. Sci. 2001, 42(13):3135-3141.
43. Ngamkitidechakul C., Warejcka D.J., Burke J.M., O[U+05F3]Brien W.J., Twining S.S. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. 2003, 278(34):31796-31806. 10.1074/jbc.M302408200.
44. Ravenhill L., Wagstaff L., Edwards D.R., Ellis V., Bass R. G-helix of Maspin mediates effects on cell migration and adhesion. J. Biol. Chem. 2010, 285(47):36285-36292. 10.1074/jbc.M110.177253.
45. Seftor R.E., Seftor E.A., Sheng S., Pemberton P.A., Sager R., Hendrix M.J. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 1998, 58(24):5681-5685.
46. Sheng S., Carey J., Seftor E.A., Dias L., Hendrix M.J., Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 1996, 93(21):11669-11674.
47. Shi H.Y., Zhang W., Liang R., Abraham S., Kittrell F.S., Medina D., Zhang M. Blocking tumour growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 2001, 61(18):6945-6951.
48. Smallbone K., Gatenby R.A., Gillies R.J., Maini P.K., Gavaghan D.J. Metabolic changes during carcinogenesis: potential impact on invasiveness. J. Theor. Biol. 2007, 224(4):703-713. 10.1016/j.jtbi.2006.09.010.
49. Teoh S.S., Vieusseux J., Prakash M., et al. Maspin is not required for embryonic development or tumour suppression. Nat. Commun. 2014, 5:3164.
50. Toma A., Mang A., Schuetz T.A., Becker S., Buzug T.M. A novel method for simulating the extracellular matrix in models of tumour growth. Comput. Math. Methods Med. 2012, 109019:11. 10.1155/2012/109019.
51. Wang Y., Chan S. Soft large margin clustering. Inf. Sci. 2013, 232:116-129. 10.1016/j.ins.2012.12.040.
52. Xiao X., Wang P., et al. Predicting protein structural classes with pseudo amino acid composition: an approach using geometric moments of cellular automaton image. J. Theor. Biol. 2008, 254:691-696. 10.1016/j.jtbi.2008.06.016.
53. Xiao X., Wang P., et al. Cellular automata and its applications in protein bioinformatics. Curr. Protein Peptide Sci. 2011, 12:508-519. 10.2174/138920311796957720.
54. Yin S., Lockett J., Meng Y., et al. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 2006, 66(8):4173-4181.
55. Young M.E., Carroad P.A., Bell R.L. Estimation of diffusion coefficients of proteins. Biotechnol. Bioeng. 1980, 22(5):947-955.
56. Zhang M., Volpert O., Shi Y.H., Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 2000, 6:196-199. 10.1038/72303.
57. Zou Z., Anisowicz A., Hendrix M.J., et al. Maspin, a serpin with tumour suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529. 10.1126/science.8290962.